Transplantation of Unique Subpopulation of Fibroblasts, Muse Cells, Ameliorates Experimental Stroke Possibly via Robust Neuronal Differentiation

Stem Cells

Volumn 34, Issue 1, 2016, Pages 160-173

  Uchida, Hiroki ^a   Morita, Takahiro ^a   Niizuma, Kuniyasu ^a   Kushida, Yoshihiro ^a   Kuroda, Yasumasa ^a   Wakao, Shohei ^a   Sakata, Hiroyuki ^a   Matsuzaka, Yoshiya ^b   Mushiake, Hajime ^b   Tominaga, Teiji ^a   Borlongan, Cesario V ^c   Dezawa, Mari ^a  

^a Department of Stem Cell Biology and Histology ^*  (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Cellular therapy; Mesenchymal stem cells; Neuronal differentiation; Pluripotent stem cells; Transplantation

Indexed keywords

CALBINDIN; CELL SURFACE MARKER; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTATHIONE TRANSFERASE P1; MICROTUBULE ASSOCIATED PROTEIN 2; NEURON SPECIFIC NUCLEAR PROTEIN; STAGE SPECIFIC EMBRYO ANTIGEN 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN ELECTROPHYSIOLOGY; BRAIN FUNCTION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN SLICE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL FATE; CELL FUNCTION; CELL LINEAGE; CELL SUBPOPULATION; CELL SURVIVAL; CELL TRANSPLANTATION; CERVICAL SPINAL CORD; COCULTURE; CONTROLLED STUDY; EVOKED SOMATOSENSORY RESPONSE; EXPERIMENTAL STROKE; FIBROBLAST; HUMAN; HUMAN CELL; MIDDLE CEREBRAL ARTERY OCCLUSION; MOTOR PERFORMANCE; MULTILINEAGE DIFFERENTIATING STRESS ENDURING CELL; NERVE CELL DIFFERENTIATION; NEURITE; NONHUMAN; RAT; SENSORIMOTOR CORTEX; SKIN FIBROBLAST; STEM CELL; ADULT; ANIMAL; ANIMAL BEHAVIOR; BRAIN; CYTOLOGY; ELECTROPHYSIOLOGY; MOTOR CORTEX; NERVE CELL; PATHOLOGY; PATHOPHYSIOLOGY; SCID MOUSE; STROKE; TRANSPLANTATION; TUMOR MICROENVIRONMENT;

ADULT; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; CELL DIFFERENTIATION; CELL LINEAGE; CELL SURVIVAL; CELLULAR MICROENVIRONMENT; ELECTROPHYSIOLOGICAL PHENOMENA; FIBROBLASTS; HUMANS; MICE, SCID; MOTOR CORTEX; NEURONS; RATS; STROKE;

EID: 84954366578     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.2206     Document Type: Article

References (39)

1. Abe K, Yamashita T, Takizawa S, et al., Stem cell therapy for cerebral ischemia: From basic science to clinical applications. J Cereb Blood Flow Metab 2012; 32: 1317-1331.
2. Lindvall O, Kokaia Z., Stem cell research in stroke: How far from the clinic? Stroke 2011; 42: 2369-2375.
3. Chen J, Li Y, Wang L, et al., Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 2001; 32: 1005-1011.
4. Chen J, Zhang ZG, Li Y, et al., Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats. Circ Res 2003; 92: 692-699.
5. Parr AM, Tator CH, Keating A., Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury. Bone Marrow Transplant 2007; 40: 609-619.
6. Honmou O, Houkin K, Matsunaga T, et al., Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke. Brain 2011; 134: 1790-1807.
7. Bliss TM, Andres RH, Steinberg GK., Optimizing the success of cell transplantation therapy for stroke. Neurobiol Dis 2010; 37: 275-283.
8. Shen LH, Li Y, Chen J, et al., One-year follow-up after bone marrow stromal cell treatment in middle-aged female rats with stroke. Stroke 2007; 38: 2150-2156.
9. Takahashi K, Yamanaka S., Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663-676.
10. Kuroda Y, Kitada M, Wakao S, et al., Unique multipotent cells in adult human mesenchymal cell populations. Proc Natl Acad Sci USA 2010; 107: 8639-8643.
11. Wakao S, Kitada M, Kuroda Y, et al., Multilineage-differentiating stress-enduring (Muse) cells are a primary source of induced pluripotent stem cells in human fibroblasts. Proc Natl Acad Sci USA 2011; 108: 9875-9880.
12. Kuroda Y, Wakao S, Kitada M, et al., Isolation, culture and evaluation of multilineage-differentiating stress-enduring (Muse) cells. Nat Protoc 2013; 8: 1391-1415.
13. Kinoshita K, Kuno S, Ishimine H, et al., Therapeutic potential of adipose-derived SSEA-3-positive muse cells for treating diabetic skin ulcers. Stem Cells Transl Med 2015; 4: 146-155.
14. Yamauchi T, Kuroda Y, Morita T, et al., Therapeutic effects of human multilineage-differentiating stress enduring (MUSE) cell transplantation into infarct brain of mice. PLoS One 2015; 10: e0116009.
15. Ogura F, Wakao S, Kuroda Y, et al., Human adipose tissue possesses a unique population of pluripotent stem cells with nontumorigenic and low telomerase activities: Potential implications in regenerative medicine. Stem Cells Dev 2014; 23: 717-728.
16. Hayase M, Kitada M, Wakao S, et al., Committed neural progenitor cells derived from genetically modified bone marrow stromal cells ameliorate deficits in a rat model of stroke. J Cereb Blood Flow Metab 2009; 29: 1409-1420.
17. Sakata H, Niizuma K, Yoshioka H, et al., Minocycline-preconditioned neural stem cells enhance neuroprotection after ischemic stroke in rats. J Neurosci 2012; 32: 3462-3473.
18. Matsuse D, Kitada M, Kohama M, et al., Human umbilical cord-derived mesenchymal stromal cells differentiate into functional Schwann cells that sustain peripheral nerve regeneration. J Neuropathol Exp Neurol 2010; 69: 973-985.
19. Matsuse D, Kitada M, Ogura F, et al., Combined transplantation of bone marrow stromal cell-derived neural progenitor cells with a collagen sponge and basic fibroblast growth factor releasing microspheres enhances recovery after cerebral ischemia in rats. Tissue Eng Part A 2011; 17: 1993-2004.
20. Mimura T, Dezawa M, Kanno H, et al., Behavioral and histological evaluation of a focal cerebral infarction rat model transplanted with neurons induced from bone marrow stromal cells. J Neuropathol Exp Neurol 2005; 64: 1108-1117.
21. Leergaard TB, Alloway KD, Pham TA, et al., Three-dimensional topography of corticopontine projections from rat sensorimotor cortex: Comparisons with corticostriatal projections reveal diverse integrative organization. J Comp Neurol 2004; 478: 306-322.
22. Chen FG, Zhang WJ, Bi D, et al., Clonal analysis of nestin(-) vimentin(+) multipotent fibroblasts isolated from human dermis. J Cell Sci 2007; 120: 2875-2883.
23. Lorenz K, Sicker M, Schmelzer E, et al., Multilineage differentiation potential of human dermal skin-derived fibroblasts. Exp Dermatol 2008; 17: 925-932.
24. Shi CM, Cheng TM., Differentiation of dermis-derived multipotent cells into insulin-producing pancreatic cells in vitro. World J Gastroenterol 2004; 10: 2550-2552.
25. Toma JG, Akhavan M, Fernandes KJ, et al., Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat Cell Biol 2001; 3: 778-784.
26. Liu Y, Kim D, Himes BT, et al., Transplants of fibroblasts genetically modified to express BDNF promote regeneration of adult rat rubrospinal axons and recovery of forelimb function. J Neurosci 1999; 19: 4370-4387.
27. Korbling M, Estrov Z., Adult stem cells for tissue repair-A new therapeutic concept? N Engl J Med 2003; 349: 570-582.
28. Kelly S, Bliss TM, Shah AK, et al., Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex. Proc Natl Acad Sci USA 2004; 101: 11839-11844.
29. Amariglio N, Hirshberg A, Scheithauer BW, et al., Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med 2009; 6: e1000029.
30. Erdo F, Buhrle C, Blunk J, et al., Host-dependent tumorigenesis of embryonic stem cell transplantation in experimental stroke. J Cereb Blood Flow Metab 2003; 23: 780-785.
31. Kawai H, Yamashita T, Ohta Y, et al., Tridermal tumorigenesis of induced pluripotent stem cells transplanted in ischemic brain. J Cereb Blood Flow Metab 2010; 30: 1487-1493.
32. Seminatore C, Polentes J, Ellman D, et al., The postischemic environment differentially impacts teratoma or tumor formation after transplantation of human embryonic stem cell-derived neural progenitors. Stroke 2010; 41: 153-159.
33. Tang Y, Yasuhara T, Hara K, et al., Transplantation of bone marrow-derived stem cells: A promising therapy for stroke. Cell Transplant 2007; 16: 159-169.
34. Borlongan CV, Glover LE, Tajiri N, et al., The great migration of bone marrow-derived stem cells toward the ischemic brain: Therapeutic implications for stroke and other neurological disorders. Prog Neurobiol 2011; 95: 213-228.
35. Xin H, Li Y, Cui Y, et al., Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats. J Cereb Blood Flow Metab 2013; 33: 1711-1715.
36. Chen J, Venkat P, Zacharek A, et al., Neurorestorative therapy for stroke. Front Hum Neurosci 2014; 8: 382.
37. Sakata H, Narasimhan P, Niizuma K, et al., Interleukin 6-preconditioned neural stem cells reduce ischaemic injury in stroke mice. Brain 2012; 135: 3298-3310.
38. Buhnemann C, Scholz A, Bernreuther C, et al., Neuronal differentiation of transplanted embryonic stem cell-derived precursors in stroke lesions of adult rats. Brain 2006; 129: 3238-3248.
39. Englund U, Bjorklund A, Wictorin K, et al., Grafted neural stem cells develop into functional pyramidal neurons and integrate into host cortical circuitry. Proc Natl Acad Sci USA 2002; 99: 17089-17094.